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An antiserum directed against a bacterial fusion protein containing UL28 protein sequences specifically recognized an
86,000 apparent Mr protein in immunoblots of wild-type capsids. This protein was not detected in immunoblots of capsids
purified from cells infected with a UL28 deletion virus, indicating that the protein was a product of UL28. The 86,000 Mr protein
was also detected in capsids purified from cells infected with mutant viruses lacking the UL6, UL15, and UL25 genes,
indicating that the UL28 protein can associate with capsids independently of successful DNA packaging and other minor
capsid components. The UL6 protein, full-length UL15 protein, and UL25-encoded proteins were also detected in capsids
purified from cells infected with the UL28 deletion virus. The UL28 and UL6 proteins remained associated with capsids treated
with 1.0 M guanidine–HCl, indicating that, like the UL6 protein, the UL28 protein was an integral component of capsids.
Amounts of UL28 protein were reduced in DNA-containing capsids and UL28 protein was not detected in virions, suggesting
that some UL28 protein is lost during the cleavage-packaging reaction. © 1998 Academic Press
INTRODUCTION
Herpes simplex virus capsid assembly culminates
with insertion of precisely cleaved genomic viral DNA
into preformed intranuclear capsids. In addition to pro-
teins required for assembly of the internal and external
capsid shells (reviewed in Homa and Brown, 1997;
Steven and Spear, 1997), DNA packaging requires the
UL6, UL15, UL17, UL25, UL28, UL32, and UL33 genes (Ad-
dison et al., 1984, 1990; Sherman and Bachenheimer,
1987; Weller et al., 1987; Al-Kobaisi et al., 1991; Poon and
Roizman, 1993; Tengelsen et al., 1993; Baines et al., 1997;
Yu et al., 1997; Lamberti and Weller, 1998; McNab et al.,
1998; Salmon et al., 1998). Thus in cells infected with
viruses carrying mutations in these genes, B capsids that
lack DNA are readily detected whereas DNA-containing
C capsids are not detected. The UL6, UL15, and UL25
gene products of HSV have been shown to associate
with capsids even in the presence of high concentrations
of guanidine (Patel and Maclean, 1995; McNab et al.,
1998; Salmon and Baines, 1998). The UL25 gene is also
capsid associated but is dispensable for cleavage of
viral DNA (McNab et al., 1998).
The observation that the assembly pathway of herpes-
viruses and some DNA containing bacteriophages ap-
pear similar suggests the possibility that subsets of HSV
DNA packaging proteins act as functional homologs of
bacteriophage packaging proteins. Bacteriophage termi-
nases help mediate DNA cleavage and transiently link
DNA to the capsid at the portal vertex into which DNA is
inserted. The observation that the human cytomegalovi-
rus homolog of HSV-1 UL28 can bind viral DNA known to
be cleaved during the cleavage/packaging reaction sug-
gests the possibility that UL28 encodes an important
component of the herpesvirus terminase (Bogner et al.,
1998). The product of the HSV-1 UL28 gene has been
identified in infected cell lysates (Pellett et al., 1986;
Tengelsen et al., 1993). The main goals of the current
studies were to determine (i) whether the UL28 gene
product, like other terminases, transiently interacts with
capsids and (ii) if capsid association of the UL28 protein
is dependent on minor HSV capsid proteins known to be
required for viral DNA cleavage and packaging.
RESULTS AND DISCUSSION
The UL28-encoded protein is associated with capsids
To determine whether the HSV-1 UL28-encoded pro-
tein was associated with viral capsids, capsids were
purified from Vero cells infected with wild-type virus,
HSV-1(F) (Ejercito et al., 1968) or the UL28 deletion virus,
gCB (Tengelsen et al., 1993). Capsids were purified on
continuous sucrose gradients, and 0.5 ml gradient frac-
tions were collected from top to bottom as indicated
under Materials and Methods. Proteins within fractions
were precipitated in acetone, electrophoretically sepa-
rated, transferred to nitrocellulose membrane, and ana-
lyzed by immunoblotting as described under Materials
and Methods. A rabbit polyclonal antiserum produced by
immunization of rabbits with full-length UL28 gene fused
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to lcro (Tengelsen et al., 1993) was used to identify
fractions containing the UL28 protein. To allow identifi-
cation of fractions containing capsids, the same mem-
branes were also incubated with a polyclonal antiserum,
NC-1 (Cohen et al., 1980), directed against the HSV-1
major capsid protein, VP5.
The anti-UL28 antiserum recognized an approximately
86,000 Mr protein in fractions of HSV-1(F) capsid gradi-
ents (Fig. 1A) but not in fractionated material from the
gCB (UL282)-infected cells (Fig. 1B). This observation
indicated that the 86,000 Mr protein was a product of the
UL28 gene. The size of the protein is in rough agreement
with the previously identified protein encoded by UL28
using a similar antiserum preparation, which detected an
87,000 Mr protein (Tengelsen et al., 1993) and an anti-
peptide antisera directed against the predicted 14 C-
terminal amino acids within the UL28 coding sequence,
which detected a protein of 95,000 apparent Mr (Pellett et
al., 1986). The UL28-specific antiserum also cross-re-
acted to some degree with the VP5 protein (Figs. 1A and
1B). Immunoblotting of the same membranes with the
VP5-specific antiserum, NC-1, demonstrated peak VP5
immunoreactivity in fractions 11–13 and fraction 16 (Fig.
1A) and fractions 12–14 (Fig. 1B) of the sucrose gradients
from HSV-1(F) and gCB-infected cells, respectively. Rel-
ative densities of the immunoreactive bands were calcu-
lated using EagleSight Software 3.2, Stratagene. The
peaks of VP5 immunoreactivity corresponded to two light
scattering bands in the HSV-1(F) sucrose gradient corre-
sponding to B (upper band) and C (lower band) capsids,
and a single light-scattering B capsid band in the gradi-
ent containing lysates of gCB-infected cells (not shown).
Although the UL28 protein was detected to a certain
extent in most fractions of the gradient, peak UL28 im-
munoreactivity coincided with VP5 immunoreactivity in
fractions containing B capsids. (Fig. 1A, fractions 12 and
13). Although there was a slight increase in the level of
UL28-specific immunoreactivity in fractions 17 and 18
from the HSV-1(F) gradient (Fig. 1A), this did not correlate
with C capsid associated VP5 immunoreactivity (Fig. 1A,
fraction 16). These observations indicate that UL28 pro-
tein is present in B capsids but is not detected in C capsids.
FIG. 1. Digital scanned images of immunoblots of HSV-1(F) and UL282 capsids probed with VP5- and UL28 protein-specific antisera. Continuous
sucrose gradients, containing capsids purified from HSV-1(F) (A) or UL282 (B) virus-infected Vero cells, were collected in 0.5-ml fractions starting at
the top of the tubes. Proteins precipitated from the fractions were electrophoretically separated on denaturing polyacrylamide gels, transferred to
nitrocellulose, and probed with the UL28-specific antiserum (aUL28) (A and B, lower panels) and the VP5 specific antiserum (aVP5) (A and B, upper
panels). The expected position of the 86,000 Mr UL28 protein is indicated.
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Although unlikely, it was possible that UL28 protein in
capsid-containing fractions reflected the presence of ag-
gregates of UL28 protein that cosedimented with capsids
in sucrose gradients rather than a direct interaction of
UL28 protein with capsids. To exclude this possibility, B
capsids were purified, treated with 0.0, 0.5, 1.0, or 2.0 M
guanidine hydrochloride (GuHCl), and analyzed by Coo-
massie blue staining and immunoblotting with the anti-
UL28 and anti-UL6 sera as described under Materials
and Methods. Densitometric analysis (EagleSight Soft-
ware 3.2, Stratagene) of the Coomassie-blue-stained
capsid proteins demonstrated that at 1.0 M GuHCl, the
core protein VP22a was reduced by 70% compared to
corresponding bands in untreated capsids and was un-
detectable at 2.0 M GuHCl (Fig. 2A and Table 1). The
VP26 protein (present at the tips of hexons) was largely
retained in capsids treated with 1.0 M GuHCl but was
reduced by ;40% upon treatment with 2.0 M GuHCl (Fig.
2A and Table 1). As expected from previously published
data (Newcomb and Brown, 1991), levels of VP5, VP19,
and VP23 within the outer capsid shell remained rela-
tively constant even in the presence of 2.0 M GuHCl,
indicating that the guanidine treatment had not com-
pletely disrupted the outer shell of capsids (Fig. 2A).
Immunoblotting of GuHCl-treated capsids with UL28- and
UL6-specific antisera (Taus et al., 1998) showed that both
proteins remained associated with capsids in 1.0 M Gu-
HCl but were reduced by ;80% in capsids extracted with
2.0 M GuHCl (Figs. 2B and 2C and Table 1). We conclude
that capsid-associated UL28 protein is as resistant to
extraction with GuHCl as the UL6 protein. These obser-
vations support the conclusion that the UL28 protein, like
the UL6 protein, is an integral component of B capsids.
The observation that peak UL28 protein immunoreac-
tivity did not correspond to the presence of C capsids in
the immunoblot of wild-type capsids suggested that UL28
protein was not a component of C capsids, the immedi-
ate precursor of virions. To test whether UL28 protein
was a virion component, virions were purified from HSV-
1(F)-infected Vero cells as described (Baines and Roiz-
man, 1993). Virion proteins were separated on a dena-
turing 15% polyacrylamide gel and electrically trans-
ferred to a nitrocellulose membrane. The membrane was
first probed with an antiserum to detect virion-associated
UL21-encoded protein (Baines et al., 1994a) and subse-
quently with the UL28-specific antiserum.
No UL28-specific immunoreactivity was detected in
virions (Fig. 3), even upon prolonged exposure of the
immunoblot. However, as judged by UL21-specific immu-
noreactivity (Fig. 3) and Coomassie blue staining (not
shown), abundant virion-associated proteins were
present on the nitrocellulose membrane. Although, as
suggested by the ECL manufacturer (Amersham), the
membrane was washed with a buffer containing 2.0%
SDS to remove UL21-specific immunoreactivity prior to
immunodetection with the UL28 antiserum, some UL21-
specific immunoreactivity remained associated with the
membrane as revealed by the presence of a band in the
right panel that comigrated with the band containing
UL21 protein. A slower migrating protein also reacted
with the UL21 antiserum and is visible in the left panel of
Fig. 3; the presence of this band does not alter the
conclusion that virion proteins were present in the left
lane of Fig. 3. We conclude that in virions, the amount of
UL28 protein is reduced to undetectable levels, whereas
the protein is readily detected in B capsids. These ob-
servations, taken together with the observation that peak
UL28 protein immunoreactivity did not coincide with su-
FIG. 2. Digital images of Coomassie-blue-stained capsid proteins
and immunoblots of capsid proteins probed with antisera directed
against UL28 and UL6 proteins. Type B capsids were purified from
HSV-1(F)-infected Vero cells and treated with 0.0, 0.5, 1.0, and 2.0 M
guanidine hydrochloride (GuHCl). (A) Electrophoretically separated
proteins stained with Coomassie blue. Positions of capsid proteins are
indicated to the right. MW, molecular weight standards. (B) Immunoblot
of GuHCl-treated capsids probed with the UL28-specific antiserum. The
positions of VP5 and the UL28 protein are indicated on the right. (C)
Immunoblot of GuHCl-treated capsids probed with the UL6-specific
antiserum. The same blot shown in (B) was probed with the UL6-
specific antiserum. Only the region containing UL6 immunoreactivity is
shown.
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crose gradient fractions containing C capsids, suggest
that during the processes of viral DNA cleavage-pack-
aging and virion maturation, the UL28 protein becomes
dissociated from the virus capsid.
The UL28-encoded protein associates with capsids in
the absence of the UL6-, UL15-, and UL25-encoded
proteins
As a first step toward deciphering the mechanism by
which the UL28 protein associates with capsids, mutant
B-like capsids were tested for the presence of the UL28
protein. Vero cells were infected with mutant viruses
lacking UL6 (UL62) (Patel et al., 1996), UL15 (HSV-1[DUL15])
(Baines et al., 1997), or UL25 (KUL25NS) (McNab et al.,
1998), and capsids were purified on sucrose gradients as
described above. Gradient fractions were analyzed for
the presence of the UL28 protein by immunoblotting.
UL28 protein-specific immunoreactivity was readily de-
tected in capsids lacking minor capsid proteins encoded
by UL6, UL15, and UL25 (Fig. 4). These data strongly
suggest that UL28 protein can associate with capsids
lacking UL6-, UL15-, and UL25-encoded proteins. A ca-
veat of this interpretation is that as yet undetected frag-
ments of UL6, UL15, and UL25, present in mutant capsids,
could mediate capsid association of the UL28 protein;
further work to characterize the mechanism of capsid
association of these minor capsid proteins is in progress.
UL6, UL15, or UL25 proteins associate with capsids
lacking UL28 protein
A polyclonal antiserum specific for the UL25 protein
was generated as described under Materials and Meth-
ods. The specificity of the antiserum was determined by
immunoblotting capsids purified from wild-type [HSV-
1(F)] and UL252 (KUL25NS) virus-infected cells, and the
results are shown in Fig. 5. A protein of apparent Mr
60,000 was detected in capsids isolated from wild-type-
infected cells but was absent from capsids purified from
UL252 virus-infected cells (Fig. 5). The fluorogram of the
nitrocellulose sheet in the right panel of Fig. 5 is darker
due to prolonged exposure of the nitrocellulose to film,
thus ensuring visualization of proteins cross reacting
with the UL25 antiserum. Although some cross-reactivity
of the antiserum to VP5 was evident (Fig. 5), the absence
of a band in UL25(2) capsids that corresponds to the
60,000 apparent Mr protein detected in wild-type capsids
supports the conclusion that this protein is the product of
the UL25 gene.
To determine whether the absence of the UL28 protein
influenced capsid association of other cleavage-packag-
ing proteins, capsids purified from Vero cells infected
with the UL282 virus (gCB) were examined for the pres-
ence of the UL6, UL15, and UL25 proteins. Gradients were
prepared and fractionated proteins were transferred to
nitrocellulose and probed with the antiserum directed
against UL25 protein or with previously described anti-
sera specific for the UL6 and UL15 proteins (Baines et al.,
1994b; Taus et al., 1998).
Results indicated that the UL6 protein, full-length UL15
protein, and UL25 proteins were readily detected in frac-
tions containing purified UL282 capsids (Fig. 6). There-
fore these proteins were not dependent on the UL28
protein for capsid association. It was also noted that, as
reported previously (Salmon and Baines, 1998), UL28(2)
capsids did not contain the 80,000 apparent Mr UL15
found to associate with B capsids purified from wild-type
virus-infected cells. However, the 80,000 apparent Mr
protein is also absent from capsids purified from cells
lacking the UL6 and UL17 gene products (Salmon and
Baines, 1998) suggesting that capsid association of this
protein requires an intact cleavage/packaging reaction
rather than specific interaction with capsid-associated
UL28 protein.
It is therefore concluded that the UL28 protein can
associate with capsids independently of both cleavage
FIG. 3. Digital images of immunoblots of virion proteins probed with
antisera directed against UL21 and UL28 proteins. Virions were purified
from HSV-1(F)-infected Vero cells as indicated in the text. Separated
proteins were probed with the UL21- and UL28-specific antisera (aUL21,
aUL28). The position of the UL21 protein is indicated to the left.
TABLE 1
Percent Protein Associated with Capsids after Treatment
with GuHCl (From data shown in Figure 2)
Protein
GuHCl (M)
0.0 0.5 1.0 2.0
VP5a 100 90 89 ND
VP22aa 100 63 34 —
VP26a 100 92 94 60
VP5b 100 112 110 94
UL28
b 100 99 55 18
UL6
b 100 73 75 18
Note. ND, not determined; —, not detected.
a Values represent relative intensities of Coomassie blue-stained
proteins from GuHCl-treated or untreated capsids.
b Values represent relative immunoreactivity of each protein calcu-
lated from immunoblots of GuHCl-treated or untreated capsids.
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and packaging and minor capsid components required
for the DNA cleavage and packaging reaction. These
data suggest that docking of the putative HSV terminase
with the capsid is due to interaction with major compo-
nents of the capsid shell. Alternatively, the UL28 protein
capsid association could be mediated by more than one
minor capsid protein required for cleavage and packag-
ing of viral DNA.
It is relevant to note that soon after submission of this
manuscript, Yu and Weller (1998), published data indicat-
ing that UL28 protein was a component of wild-type and
mutant B capsids but not C capsids.
MATERIALS AND METHODS
Cells and viruses
Vero cells and transformed cell lines were maintained
in Dulbecco’s modified Eagle medium supplemented
with 10% newborn calf serum, penicillin, and streptomy-
FIG. 4. Digital images of immunoblots of capsids isolated from UL62, UL152, and UL252 virus-infected cells probed with the UL28 protein-specific
antiserum (aUL28). The positions of VP5 and UL28 protein are indicated to the right of each panel.
FIG. 5. Digital images of immunoblots of HSV-1(F) and UL252 cap-
sids probed with anti-UL25-specific antiserum. Electrophoretically sep-
arated capsid proteins from HSV-1(F) (WT) or UL252 virus capsids
were probed with the UL25-specific antiserum. The position of the UL25
protein is indicated to the left.
FIG. 6. Digital images of an immunoblot of UL282 capsids probed
with UL6-, UL15-, and UL25 protein-specific antisera (aUL6, aUL15, aUL25).
The same nitrocellulose membrane was probed with all three antisera.
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cin. The transformed cell lines G33, clone 17, 8–1, and C1
were used for the propagation of the UL6, UL15, UL25,
and UL28 mutant viruses, respectively. These cell lines,
the wild-type [HSV-1(F)] and mutant viruses lacking UL6
(UL62), UL15 [HSV-1(DUL15)], UL25 (KUL25NS), and UL28
(gCB) have been previously described (Ejercito et al.,
1968; Tengelsen et al., 1993; Baines et al., 1997; McNab
et al., 1998; Patel et al., 1996).
Capsid and virion purification and analysis
Vero cells were infected with HSV-1(F) or mutant vi-
ruses and capsids were purified from nuclear lysates on
20–50% continuous sucrose gradients as previously de-
scribed (Perdue et al., 1974; Salmon and Baines, 1998).
Gradient fractions (0.5 ml) were collected from top to
bottom with a fractionating device (Auto Densi-Flow IIC,
Haake Buchler). Protein within fractions was precipitated
in acetone, collected by centrifugation, and electro-
phoretically separated on 10% denaturing polyacryl-
amide gels. Separated proteins were electrically trans-
ferred to nitrocellulose membranes and analyzed by im-
munoblotting. In some cases, purified B capsids were
collected from sucrose gradients with a Pasteur pipette
and pelleted by centrifugation. The capsids were resus-
pended in TNE and treated with 0.0, 0.5, 1.0, or 2.0 M
guanidine hydrochloride (GuHCl), and treated capsids
were collected by centrifugation through a sucrose cush-
ion as described previously (Newcomb and Brown, 1991;
Salmon and Baines, 1998). Unless otherwise noted, cap-
sid proteins were electrophoretically separated on a 12%
denaturing polyacrylamide gel and analyzed by Coomas-
sie blue staining and immunoblotting. Virions were puri-
fied from Vero cells infected with HSV-1(F) and analyzed
by immunoblotting, as previously described (Baines and
Roizman, 1993; Spear and Roizman, 1972).
Antibodies and immunoblotting
Antisera specific for the UL6, UL15, UL21, and UL28
proteins and VP5 have been described (Baines et al.,
1994a, 1994b; Cohen et al., 1980; Taus et al., 1998;
Tengelsen et al., 1993). Immunoblotting was done essen-
tially as previously described (Baines and Roizman,
1993). Briefly, electrophoretically separated capsid and
virion proteins were transferred to nitrocellulose and
probed with various antisera, diluted in PBS plus 1%
BSA and 1% Tween 20, as indicated in the text [anti-UL6
1:100, anti-UL15 1:1000, anti-UL21 1:400, anti-UL25 1:1000,
anti-UL28 1:1000, anti-VP5 (NC-1) 1:5000]. Bound immu-
noglobulin was visualized using the ECL system accord-
ing to the directions of the manufacturer (Amersham)
[anti-UL6, -UL15, -UL25, -UL28] or with alkaline phospha-
tase conjugated donkey anti-rabbit immunoglobulin
(Jackson ImmunoResearch) as previously described
(Baines and Roizman, 1993; Salmon and Baines, 1998)
[anti-UL21, VP5].
Antiserum production
A 740-bp DNA fragment containing the C-terminal 239
amino acids of UL25 (McGeoch et al., 1988) was ligated
into pGEX-3X (Pharmacia) to place UL25 in frame with
glutathione-S-transferase (GST). The plasmid, pJB128,
was sequenced at the junction of the two genes to
ensure that the open reading frame encoding the fusion
protein was maintained (not shown). Expression of the
soluble fusion protein (UL25GST) was induced by the
addition of IPTG to a final concentration of 0.1 mM, and
UL25GST was purified by affinity chromatography on
glutathione–Sepharose beads (Pharmacia Biotech AB,
Uppsala, Sweden). The purified protein was eluted in 10
mM glutathione and was used to immunize New Zealand
White rabbits as previously described (Baines and Roiz-
man, 1993).
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